Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,255.6
8.4 (0.26%)

 

  • STI Straits Times Index
    3,255.6
    8.4 (0.26%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,581.9
    -5.5 (-0.34%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,352.1
    366.8 (1.31%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,060.8
    8.6 (0.28%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    24,031.3
    166.8 (0.70%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,227.2
    -11.0 (-0.18%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,267.2
    27.6 (1.23%)
    Index delayed 20 minutes
  • XAO XAO
    7,249.0
    68.5 (0.95%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,299.7M
  • Value: 689.7M
  • Rise: 134
  • Fall: 162
  • Unch: 523

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Medtecs Intl0.101+0.009
AsiaMedic0.017-0.001
Healthway Med0.044+0.004
P5 Capital0.034-0.001
AusGroup^0.043-0.002
Ntegrator Intl0.015+0.002
Thomson Medical0.064+0.001
YZJ Shipbldg SGD1.090-0.010
Golden Agri-Res0.225-0.005
DISA0.003-

World Indices

World Indices
Name Last Change
Nasdaq 9,370.8 -18.1
HSI 28,359.9 +374.6
HSCEI 11,190.4 +220.3
Jakarta 6,231.6 -6.5
Nikkei 225 24,031.3 +166.8
SSE Comp 3,060.8 +8.6
Shanghai A 3,207.1 +9.0
Shanghai B 257.5 +0.2
PSE Comp 0.0
KOSPI 2,267.2 +27.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NEUREN PHARMACEUTICALS LTD NEUREN PHARMACEUTICALS
Updated on 21 Jan 2020 (End of trading day)
Last (AUD): 2.830 Change: +0.030 High: 2.830 Remarks: -
Change (%): +1.07 Low: 2.780
Open 2.790 Yesterday's Close 2.8000000000000003
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 15,874 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a 0.02979 Trailing EPS (AUD) e -0.00694 NAV (AUD) b 0.1626
PE a 94.998 Trailing PE f - Price / NAV b 17.4047
Dividend (AUD) d - Cash In Hand (AUD) g 0.1674 Issued & Paid-up Shares c 103,170,000
Dividend Yield (%) d - Price / Cash In Hand g 16.906 Treasury Shares h -
Beta - 75 Daysi 0.751 R-Squared - 75 Days(%)i 1.19 Market Cap (M) 291.971
Beta - 500 Daysi 0.619 R-Squared - 500 Days (%)i 1.04 Enterprise Value (M) 274.704
Piotroski F Score 5 Exchange Code NEU Par Value ( NZD ) n.a.
52 Weeks Volatility (%) 48.85 Free Float (%) 53.9
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 24 May 2018.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 16 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NEUREN PHARMACEUTICALS LTD ASX 291.971 94.998 - 17.4047 -
Industry Biotechnology ASX 2,906.627 63.278 62.701 16.8171 0.829
Local Peer CSL ASX 138,131.100 51.485 51.485 18.4589 0.872
Local Peer POLYNOVO LIMITED ASX 1,685.774 - - 64.5570 -
Local Peer AVITA MEDICAL LTD ASX 1,556.340 - - 52.1277 -
Local Peer MESOBLAST LTD ASX 1,407.857 - - 1.9983 -
Local Peer NEXT SCIENCE LTD ASX 403.334 - - 11.5942 -
Local Peer TELIX PHARMACEUTIC ASX 377.387 - - 8.7339 -
Local Peer RESAPP HEALTH LIMITED ASX 208.877 - - 27.2727 -
Local Peer PYC THERAPEUTICS LIMITED ASX 190.543 - - 30.9524 -
Local Peer IMUGENE LIMITED ASX 154.909 - - 5.6452 -
Local Peer CYNATA THERAPEUTICS LTD ASX 123.622 - - 11.2676 -
Local Peer IMMUTEP LTD ASX 115.531 - - -6.7816 -
Local Peer ONCOSIL MEDICAL LIMITED ASX 107.221 - - 10.0592 -
Other Local Peers ORTHOCELL LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), ANTEOTECH LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), MEMPHASYS LTD (ASX), BIOTRON (ASX), BIONOMICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), GENETIC TECHNOLOGIES (ASX), TALI DIGITAL LIMITED (ASX), RHINOMED LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), IMMURON LIMITED (ASX), PATRYS LIMITED (ASX), CELLMID LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), REGENEUS LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), ADALTA LTD (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BENITEC BIOPHARMA LTD (ASX), BIOXYNE LIMITED (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), MEDIBIO LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), BPH ENERGY LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 141,178.118 16.819 17.501 12.9201 2.355
Global Peer GILEAD SCIENCES INC NASDAQ 79,236.345 14.525 29.423 3.8457 3.689
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer VERTEX PHARMACEUTICAL NASDAQ 60,170.529 28.702 28.068 11.4536 -
Global Peer BIOGEN INC NASDAQ 51,821.138 11.696 9.604 3.7026 -
Global Peer ILLUMINA INC NASDAQ 48,264.510 58.432 49.604 10.8728 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 39,933.892 16.337 18.624 3.8016 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,795.499 87.961 25.953 5.8541 0.682
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 25,008.096 322.269 17.009 2.4122 -
Global Peer SINO BIOPHARM HKEx 151,866.775 14.173 14.710 4.5227 0.606
Other Global Peers SEATTLE GENETICS INC (NASDAQ), WUXI BIO (HKEx), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BEIGENE (HKEx), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), REPLIGEN CORP (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), GENSCRIPT BIO (HKEx), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), FIBROGEN INC (NASDAQ), 3SBIO (HKEx), AGIOS PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), NATERA INC (NASDAQ), UNIQURE N.V. (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), KODIAK SCIENCES INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), EPIZYME INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), XENCOR INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ARVINAS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), REGENXBIO INC (NASDAQ), HAOHAI BIOTEC (HKEx), ALPHAMAB-B (HKEx), INTRA-CELLUAR THERAPIES INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), CORTEXYME INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), VERACYTE INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), NEXTCURE INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), FRONTAGE (HKEx), NANOSTRING TECHNOLOGIES INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), CKLIFE SCIENCES (HKEx), KARYOPHARM THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), OPKO HEALTH INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), RADIUS HEALTH INC (NASDAQ), VIVA BIOTECH (HKEx), ACHILLION PHARMACEUTICALS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ASCENTAGE-B (HKEx), MEIRAGTX HOLDINGS PLC (NASDAQ), OMEROS CORP (NASDAQ), KADMON HLDGS INC (NYSE), NANTKWEST INC (NASDAQ), AVROBIO INC (NASDAQ), CYTOKINETICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), IMMUNOGEN INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MACROGENICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), SINOMAB BIO-B (HKEx), AGENUS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MERUS B V (NASDAQ), BELLUS HEALTH INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), SINOVAC BIOTECH LTD (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ASCLETIS-B (HKEx), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ESSEX BIO-TECH (HKEx), PROGENICS PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CABALETTA BIO INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PERSONALIS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), LEE'S PHARM (HKEx), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), IVERIC BIO INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), PFENEX INC (NYSE American), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GERON CORP (NASDAQ), DPHARMA (Bursa), EVOFEM BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), KAMADA (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), BBI LIFE SCI (HKEx), AFFIMED N V (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), XOMA CORP (NASDAQ), GLYCOMIMETICS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CHIASMA INC (NASDAQ), IMV INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), NOVAVAX INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), SAVARA INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CHIMERIX INC (NASDAQ), ENZO BIOCHEM INC (NYSE), UNI-BIO GROUP (HKEx), FENNEC PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), HARVARD BIOSCIENCE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), AXCELLA HEALTH INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ADURO BIOTECH INC (NASDAQ), OTONOMY INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), COHBAR INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SYNLOGIC INC (NASDAQ), INFLARX N V (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CEL-SCI CORP (NYSE American), MICROBOT MEDICAL INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), TREVENA INC (NASDAQ), EQUILLIUM INC (NASDAQ), VERMILLION INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), PLURISTEM THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), ADVAXIS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), RESTORBIO INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CT ENTERPRISE (HKEx), VASCULAR BIOGENICS LTD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), ISORAY INC (NYSE American), ZAFGEN INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BIOSINO BIO-TEC (HKEx), OCUGEN INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), BIONANO GENOMICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), REGENT PACIFIC (HKEx), AEVI GENOMIC MEDIC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), ATYR PHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), ORAGENICS INC (NYSE American), SOPHIRIS BIO INC (NASDAQ), EXTRAWELL PHAR (HKEx), ACTINIUM PHARMACEUTICALS INC (NYSE American), BIO-PATH HOLDINGS INC (NASDAQ), IBIO INC (NYSE American), AETERNA ZENTARIS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), MIRAGEN THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), VAXART INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), PRECIPIO INC (NASDAQ), SENESTECH INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), BIOCEPT INC (NASDAQ), TOCAGEN INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), Suntar Eco-City^ (SGX), CYCLACEL PHARMA IN (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TROVAGENE INC (NASDAQ), OPGEN INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), QT Vascular (SGX), MGRC (Bursa), HAO WEN HLDGS (HKEx), SENECA BIOPHARMA INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), SPHERIX INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.060
-2.08 %
10 Days -+0.260
+10.12 %
20 Days -+0.480
+20.43 %
Medium Term Return 3 Months -+0.350
+14.11 %
6 Months -+1.430
+102.14 %
1 Year -+1.445
+104.33 %
Long Term Return 2 Years --0.290
-9.29 %
3 Years -+1.510
+114.39 %
5 Years --0.570
-16.76 %
Annualised Return Annualised --
-3.60 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.980 - 2.890 Change From 1 Year Low +1.850 % Change From 1 Year Low (%) +188.78
Change From 1 Year High -0.060 % Change From 1 Year High (%) -2.08
2 Years Range 0.980 - 3.600 Change From 2 Years Low +1.850 % Change From 2 Years Low (%) +188.78
Change From 2 Years High -0.770 % Change From 2 Years High (%) -21.39
5 Years Range 0.155 - 3.600 Change From 5 Years Low +2.675 % Change From 5 Years Low (%) +1725.81
Change From 5 Years High -0.770 % Change From 5 Years High (%) -21.39
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Neuren Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment and neurodegenerative disorders. The company was founded on December 17, 2001 and is headquartered in Melbourne, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
21 Jan 2020 2.790 2.830 2.780 2.830 15,874 -
20 Jan 2020 2.760 2.830 2.720 2.800 70,847 -
17 Jan 2020 2.820 2.850 2.710 2.800 93,207 -
16 Jan 2020 2.860 2.860 2.800 2.820 41,350 -
15 Jan 2020 2.820 2.880 2.800 2.880 49,410 -
14 Jan 2020 2.720 2.890 2.720 2.890 301,342 -
13 Jan 2020 2.540 2.750 2.520 2.700 227,504 -
10 Jan 2020 2.600 2.600 2.510 2.600 51,344 -
09 Jan 2020 2.600 2.610 2.550 2.600 36,483 -
08 Jan 2020 2.600 2.600 2.510 2.530 35,442 -
07 Jan 2020 2.610 2.620 2.550 2.570 34,559 -
06 Jan 2020 2.590 2.610 2.570 2.610 51,204 -
03 Jan 2020 2.430 2.620 2.430 2.610 163,508 -
02 Jan 2020 2.480 2.480 2.450 2.450 19,709 -
31 Dec 2019 2.460 2.480 2.450 2.480 5,443 -
30 Dec 2019 2.400 2.490 2.380 2.490 32,819 -
27 Dec 2019 2.330 2.400 2.330 2.400 25,453 -
24 Dec 2019 2.340 2.380 2.320 2.350 10,120 -
23 Dec 2019 2.360 2.390 2.320 2.390 16,942 -
20 Dec 2019 2.400 2.400 2.360 2.360 20,061 -
19 Dec 2019 2.370 2.400 2.370 2.400 34,323 -
18 Dec 2019 2.410 2.450 2.360 2.360 40,223 -
Summary
Current 2 Weeks
(08 Jan 2020 to 21 Jan 2020)
2.600 2.890 2.510 2.830 922,803 -
Previous 2 Weeks
(20 Dec 2019 to 07 Jan 2020)
2.400 2.890 2.360 2.570 379,818 -
4 Weeks from
(22 Nov 2019 to 19 Dec 2019)
2.430 2.890 2.390 2.400 1,261,975 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.